In mouse models of mesothelioma and fibrosarcoma, ATRA reduces the number of peripheral MDSCs and it induces an interferon-driven inflammatory tumor micro-environment enriched in CD8+ T-cells. The gene discussed is CD8A; the disease is neoplasm.